Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering, while Jones Day advised EDAP. EDAP TMS S.A. executed its $28 million public offering of 4,150,000 American depositary shares,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Recursion Pharmaceuticals, Inc. executed its $500 million initial public offering of 27,878,787 shares of Class...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Alkami in the offering, Davis Polk advised the representatives of the several underwriters. Alkami Technology, Inc., a leading cloud-based digital banking...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several purchasers in offering. Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. The $646.9 million secondary offering of 20,700,000 shares of common stock of Maravai LifeSciences Holdings, Inc....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the initial purchasers in the offering. The $2 billion in aggregate principal amount of senior notes issued by Marvell Technology, Inc., a wholly owned...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Ultra Clean Holdings on the deal. Ultra Clean Holdings, Inc. executed its SEC-registered follow-on public offering of 3,181,818 shares of common stock for...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the initial purchasers on the offering. Carvana Co. executed its debt offering of $600 million aggregate principal amount of its 5.500%...
You must be a Standard 1 Year member to access this content.
